This symposium will review some of the latest trials of CF therapies including both CFTR modulators and anti-inflammatory therapy. Clinical trail data will be presented and put into context with previous work in the field as well as an outlook where the field will be moving towards in the near future.
Define the latest developments in CF therapies.
Express the challenges for clinical trials addressing specific aspects of the disease.
Define how we learn from both successful trials and those that have failed.